TI Pharma

We worked with the Dutch not-for-profit medical research enabler on their most recent Annual report and summary of their years work. The FES funded report is an opportunity to update their academic and pharmaceutical partners on the impact their research and funding has had – this new report also marked an important shift in TI Pharma’s need to move from being almost entirely government funded to a more commercially relevant connection with the private sector.